chrisvoncsefalvay/vaers-outcomes huggingface dataset:
About 30 minutes after receiving the vaccine I started to itch on my neck. This quickly spread over my entire body, especially around the eyes, arms, back, and neck. I went back to the doctor's office and they gave me a shot of Decadron in my buttocks. This has been around 40 minutes and the itching seems to have gotten better, but is still not gone.
Cough and wheezing starting about 48 hours after 2nd COVID vaccine (Moderna). Symptoms lasted approximately 1 week. Resolved after using Albuterol and Alvesco inhalers.
An ASPP (Anonymised Single Pt Print) was received from the regulatory authority on 11/4/02, concerning an 81 year old female pt who collapsed and was hospitalized after receiving a Fluvirin vaccine on 10/18/02. On 10/18/02, the pt collapsed after receiving a Fluvirin vaccine on 10/18. At the time of reporting the pt had recovered without any neurological sequelae. The reporter assessed the event as possibly vasovagal in origin. No further info was given. There was insufficient info to determine to reporter's causality assessment.
Experienced Severe chills and uncontrollable shivering, with a fever. I had aching muscles (legs), and couldn?t lift or move my left arm . Slight nausea and headache. Tylenol helped reduce severity of chills and fever.  Moderna COVID-19 Vaccine EUA
Right side of face cheekbone area swelled (NO fillers!!),  went numb to the touch but deeply painful for the next 5/6 days
Post vax, the patient developed induration 3cm x 4 cm with raised erythema.
Two bloody stools on the evening of vaccines, one spot of blood on 06/08/2010. Normal stools after that.
Patient previously tested positive for COVID in November 2020.  Patient received both doses of Moderna COVID vaccine.  Patient admitted to our hospital on 3/24/2021 for bloody stool.  CTA revealed bleed duodenal ulcer which is believed to by caused by the patient's frequent NSAID use.  Patient also tested positive for COVID upon admission, but had no symptoms.  Patient received no treatment for COVID and was discharged on 3/28 with full recovery of the ulcer.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 35-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 12Nov2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 35 years, in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "immunocompromised" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Gluten, reaction(s): "allergies gluten", notes: known allergies gluten. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 29Jun2022, outcome "recovering" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Unknown results; (29Jun2022) positive, notes: Paxlovid was taken within 5 hours of testing positive. Therapeutic measures were taken as a result of Drug ineffective, covid-19; included Paxlovid from 29Jun2022 to 03Jul2022.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Feb-2021, the patient experienced VACCINATION SITE RASH (Rash at the injection site). At the time of the report, VACCINATION SITE RASH (Rash at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.
little soreness in my arm at the injection site; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A 84 year-old patient received bnt162b2 (BNT162B2), intramuscular, administered in deltoid right, administration date 05Mar2021 13:30 (Lot number: EN6205) as dose 1, single and intramuscular, administered in deltoid right, administration date 26Mar2021 13:10 (Lot number: EN6204) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 2021, outcome "unknown", described as "little soreness in my arm at the injection site". Additional information: A patient did not receive any other vaccine in 4 weeks prior vaccination. A patients concomitant medication, medical history and relevant test was unknown. Patient stated "received my Pfizer shot for covid-19, I didn't have hardly any side effects except for a little soreness in my arm at the injection site."  No follow-up attempts are possible. No further information is expected.
Right leg where the shots were given is red, warm to touch, has hard lump. Using Tylenol, Ibuprofen, and icing. improvement after 1 week, but still has lump and slightly red.
9 cm redness with clear blisters at injection site, induration at varicella inj site.
menstrual cycle didn't  came back this month; unbearable migraines around 6 or 7 in the morning and lingers for about an hour.; This spontaneous case was reported by a consumer and describes the occurrence of AMENORRHOEA (menstrual cycle didn't  came back this month) and MIGRAINE (unbearable migraines around 6 or 7 in the morning and lingers for about an hour.) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036C21A and 051C21A) for COVID-19 vaccination.     Concurrent medical conditions included Anxiety.   On 21-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced AMENORRHOEA (menstrual cycle didn't  came back this month) and MIGRAINE (unbearable migraines around 6 or 7 in the morning and lingers for about an hour.). The patient was treated with PARACETAMOL (TYLENOL EXTRA STRENGTH) for Adverse event, at an unspecified dose and frequency. At the time of the report, AMENORRHOEA (menstrual cycle didn't  came back this month) had not resolved and MIGRAINE (unbearable migraines around 6 or 7 in the morning and lingers for about an hour.) outcome was unknown.            Concomitant product included unspecified medications for Anxiety.
Feeling hot; aches or pain; FEEELING OFF; Decreased or no appetite; Sore throat; Cough; Cold; possible upper respiratory infection symptoms; CONGESTION; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (Feeling hot), PAIN (aches or pain), FEELING ABNORMAL (FEEELING OFF), DECREASED APPETITE (Decreased or no appetite) and OROPHARYNGEAL PAIN (Sore throat) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) for Plaque psoriasis.    No Medical History information was reported.   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Jun-2022, the patient started RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) (Subcutaneous) at an unspecified dose. On 24-Jun-2022, the patient experienced FEELING HOT (Feeling hot), PAIN (aches or pain), FEELING ABNORMAL (FEEELING OFF), DECREASED APPETITE (Decreased or no appetite), OROPHARYNGEAL PAIN (Sore throat), COUGH (Cough), NASOPHARYNGITIS (Cold), UPPER RESPIRATORY TRACT INFECTION (possible upper respiratory infection symptoms) and UNEVALUABLE EVENT (CONGESTION). At the time of the report, FEELING HOT (Feeling hot), PAIN (aches or pain), FEELING ABNORMAL (FEEELING OFF), DECREASED APPETITE (Decreased or no appetite), OROPHARYNGEAL PAIN (Sore throat), COUGH (Cough), NASOPHARYNGITIS (Cold), UPPER RESPIRATORY TRACT INFECTION (possible upper respiratory infection symptoms) and UNEVALUABLE EVENT (CONGESTION) was resolving.            No concomitant medications was provided by the reporter. On 26-Jun-2022, symptoms resolved by late but not feeling 100 percent. on 27-Jun-2022 closer to 90 percent. She had relatively same reaction but with more severe and longer symptoms with covid vaccines.  The reporter's causality for the event(s) of hot, aches/pain, feeling off, decreased/no appetite, sore throat, cough, cold, possible upper respiratory infection symptoms and congestion with skyrizi(risankizumab) was a reasonable possibility. It was unknown if patient was enrolled in a COVID-19 Vaccine Trial. No treatment medications was provided by the reporter.
Severe headache, whole body pain, sore throat, eye pain, fever, severe cold, severe tremors, nausea, dizziness, swelling, redness, fatigue, muscle pain, cough, and sneezing.
Received Hep A, Influenza, and PCV7 on 11/5/08.  Had febrile seizure in am of 11/07/08.  See at Hospital ED.
Client woke up with blindness in eyes 8/22/2022 after receiving the COVID 19 Moderna vaccine 8/3/2022. Left eye was much worse than the right eye with pain included.  Went to eye center could not get seen. Went to Emergency Room, was referred back to the eye doctor. Was given some eye drops and called 8/23/2022 early morning to got to Hospital for immediate admission.
Headache for 24 hrs. ( 4/2-4/3)     slight fewer for about 6hrs 4/2/21  11:30-6:00 pm.    sore arm 3 days
Patient was administered MMR, Varicella and T-D vaccine while 5 wks pregnant.
Information has been received from a physician concerning a 1 year old patient who was vaccinated with three doses of Rotateq. In approximately March 2007, the patient developed intussusception. Medical attention was sought in the physician's office. The outcome was unknown at the time of this report. There was no product quality complaint. Upon internal review, intussusception was determined to be an other important medical event. This is one of several reports from the same source. No further information is available.
Case number PHEH2013US014330, is an initial spontaneous report received from a healthcare professional (office manager) on 01 Jul 2013. This report refers to an 18-year-old female patient. Her medical history and concomitant medication were not reported. She inadvertently received only Men A lyophilized conjugate component of MENVEO (batch number: A12006) reconstituted with another sterile diluent intramuscularly on 28 Jun 2013 instead of Men C, W, Y component of MENVEO. No adverse reaction was reported following this administration error.
(Left upper arm), Swelling and tenderness down the posterior aspect of the LT arm. Advised to apply cold compress and administer Motrin as needed. RTC if systemic fever.
This report is regarding the Pfizer COVID-19 vaccination you received on the above date, which was lot number FD0809. The Public Health District, per guidance from the Centers for Disease Control and Prevention (CDC), and Pfizer have determined that the dose of vaccine that you received is valid.
Started running fever 104 18MAR91 & was dx viral infect; Cont w/fever until 24MAR91 was adm to hosp 23MAR91 w/sinus infection; D/C 26MAR91 cont to have diarrhea @ present w/rash; no fever since 24MAR91;
fever 102 started 2 days p/vax lasted x 3 days;rash noticed 19/9/99 worse by 10/11/99;
Exhaustion, fatigue, chest pain, difficulty breathing over 2 days ER visit 3rd day with admit to hospital
Bloodly urine; gfr to 42 (from >60); kidney damage; Now stage 3b kidney dosease; This is a spontaneous report from a contactable Other HCP(patient). A 33-year-old female non-pregnant patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on 28Jan2021 14:00 (Batch/Lot Number: EL3302) at the age of 33-year-old, as single dose for covid-19 immunisation. Medical history included hypothyroidism. The patient previously received first dose of bnt162b2 on 06Jan2021 02:00 PM(lot number: El1284) at the age of 33-year-old at right arm for Covid-19 immunization. There was no other vaccine in four weeks. The patient had no covid prior vaccination. The patient had no known allergies. Concomitant medication included levothyroxine taken for an unspecified indication, start and stop date were not reported. The patient experienced bloodly urine on 29Jan2021 16:00 with outcome of not recovered, gfr to 42 (from >60) on 29Jan2021 16:00 with outcome of not recovered, kidney damage on 29Jan2021 16:00 with outcome of not recovered, now stage 3b kidney disease on 29Jan2021 16:00 with outcome of not recovered. Events resulted in [Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Disability or permanent damage]. Treatment received for the event on 30Jan2021. Covid test type post vaccination was Nasal Swab with unknown results.; Sender's Comments: The reported bloodly urine, GFR decreased, kidney damage, now stage 3b kidney disease are unlikely related to the COVID19 vaccine, BNT162B2, administration. More information regarding the patient's underlying medical condition is required for the Company to make a more meaningful causality assessment.   The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RA, IEC, as appropriate.
migraine headache; pain at injection site (Left); This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (migraine headache) and VACCINATION SITE PAIN (pain at injection site (Left)) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026A21A and 015Z20A) for COVID-19 vaccination.     The patient's past medical history included Migraine.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Mar-2021, the patient experienced HEADACHE (migraine headache) and VACCINATION SITE PAIN (pain at injection site (Left)). At the time of the report, HEADACHE (migraine headache) and VACCINATION SITE PAIN (pain at injection site (Left)) outcome was unknown. Not Provided          No concomitant medications was reported Treatment information was not provided
I had severe chest pain and could not breathe. I also experienced swelling in my face, hands and feet. My  throat felt like it closed and I also felt like I needed oxygen. I had to stand up and was breathing very hard for several minutes and nauseous. This went on for three days, on and off throughout each day. I almost went to emergency room
This was after 2nd Covid vaccination: Cannot recall exact time of onset.  Severe migraine that lasted more than 48-60 hours. Patient (self) has history of migraines. This one was much more intense and debilitating than ?usual? migraines. Did not respond to migraine medication (Aleve & Imitrex) as I typically get relief from medication within 2 hrs or so. Pain eventually lessened somewhat after 2nd dose of Imitrex. Typically migraine resolves after one dose. Phoned doctor for consult as migraine was too debilitating to drive to doctor office or leave home. Migraine eventually subsided after 2 separate doses of Imitrex. Rebound headache after 48 hrs, treated with 2 Aleve, then back to normal. Entire episode lasted about 3 days.  Also had some mild-moderate injection site pain that lasted about 3 days.
pt recv vax 5FEB96 & 4SEP97 pt had heavy exposure to chickenpox;4SEP96 pt devel pneumonia & was treated w/amoxicillin-clavulanic acid & pred x 5 days;16SEP97 pt broke out w/35 mild chickenpox lesions;
Leg muscles sore, back pain anthralgia and myalgia- 2 weeks post injection. Leg muscles still sore as of 7/02//08.
Dizziness, pale, chills, sweating a lot, abdominal pain. Got pulse 72. BP 115/87.
Patient says she has had arm pain since her vaccine, and says this happens each year after the flu vaccine. She says she has had pain since the vaccine. Pharmacist on duty recommended patient follow up with her PCP as she has already tried over the counter analgesics with no relief.
I spoke with patient the morning after administering the vaccine and she reported a small bruise at the injection. Redness/swelling was denied at that time. I advised her to continue to monitor and consult her physician if other symptoms developed. On 12/15/16 she spoke with the Senior Center Director (where clinic was conducted on 12/7/16) and showed her the injection site. The Senior Center Director took a picture of her left upper arm and sent it to me. There was significant bruising noted around the injection and redness that extended from the injection site almost to the elbow. The Senior Center Director advised pt to follow up with her PCP. I spoke with the PCP office who confirmed that patient has an appointment tomorrow (12/16/16). Medical Advisor informed.
Information has been received from a nurse practitioner concerning a 6 year old male with no pertinent medical history or allergies who on 07 Aug 2006 was vaccinated subcutaneously into the right arm with a second dose of 0.5mL dose of varicella virus vaccine live (Oka/Merck) (Lot # 649998/0909R). There was no illness at the time of vaccination. The patient developed a mild case of breakthrough with a typical rash. On 04- JUN 2007, the patient was "brought in" for an itchy rash. Subsequently, the patient recovered. There were no lab diagnostic tests performed. No further information was reported. Unspecified medical attention was sought. No product quality complaint was involved. Additional information is not expected.
Developed a papular (sand paper) like rash on trunk, upper and lower extremities within 24 hours, post vax. Also had a low-grade temperature  the day after vaccines. (+) cough; otherwise, normal exam.
stomach pain; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN (stomach pain) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ABDOMINAL PAIN (stomach pain). At the time of the report, ABDOMINAL PAIN (stomach pain) outcome was unknown. Not Provided          No concomitant medication included.  No treatment medication included.  Action taken with mRNA-1273 Moderna COVID-19 Vaccine was not applicable   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: Non significant follow up Received on 25-May-2021, No new information
Right arm was extremely sore had a hard time lifting it, then it moved into my back both shoulder blades and below. Back felt like it was going to break in half when I sneezed.  First I thought it was from shoveling snow.  Then I watched new grandbaby for three months. So didn't go to the doctor until April 29.
Pt called stating she went to the hospital 10 days after receiving the vaccine and the hospital diagnosed her with Bell's Palsy and stated that it was due to the shingles vaccine.
Pfizer-BioNTech covid-19 Vaccine EUA:  Sore arm 1st day after about 4 hours - better by next morning, no other symptoms until 3 days after the shot then I had Chills, Fever (101.8) Nausea, Fatigue, Headache. These went away within 24 hours but a bout of Diverticulitis had started up right when the symptoms started and made everything feel worse than it would have. Went to doctor and was put on antibiotics the following Wednesday.
4 moths since last period; Got second dose recently on 07Aug2021; This spontaneous case was reported by a consumer and describes the occurrence of MENSTRUATION DELAYED (4 moths since last period) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Got second dose recently on 07Aug2021) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 052E21A and 025A2114) for COVID-19 vaccination.     Concurrent medical conditions included Polycystic ovarian syndrome.   On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Aug-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Got second dose recently on 07Aug2021). On an unknown date, the patient experienced MENSTRUATION DELAYED (4 moths since last period). On 07-Aug-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Got second dose recently on 07Aug2021) had resolved. At the time of the report, MENSTRUATION DELAYED (4 moths since last period) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Pregnancy test: negative (Negative) Not pregnant.         No concomitant medications were reported. No treatment information was provided.
got Covid about 6 months after receiving Pfizer vaccines; got Covid about 6 months after receiving Pfizer vaccines; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). Other Case identifier(s): 2022NVX-US-000004306.  A male patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "got Covid about 6 months after receiving Pfizer vaccines". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: positive, notes: patient got Covid about 6 months after receiving Pfizer vaccines.  Clinical course: Adverse Event Information: On 22Nov2022, it was reported that a patient started treatment on an unspecified date with Pfizer BioNTech COVID-19 vaccine as primary series for COVID-19 immunization. It was reported the patient got Covid about 6 months after receiving Pfizer vaccines and then received 3rd shot (1st booster dose) of Pfizer. No further follow-up was anticipated.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.